Neuronal Targets for Reducing Mutant Huntingtin Expression to Ameliorate Disease in a Mouse Model of Huntington's Disease

Nature Medicine - United Kingdom
doi 10.1038/nm.3514
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Potential Neuroprotective Drug Evp4593 Reduces Excessive Expression of Huntingtin in iPSC-Based Juvenile Model of Huntington's Disease

Biophysical Journal
Biophysics
2019English

‘Tissue’ Transglutaminase Ablation Reduces Neuronal Death and Prolongs Survival in a Mouse Model of Huntington's Disease

Cell Death and Differentiation
Cell BiologyMolecular Biology
2002English

“Huntingtin Holiday”: Progress Toward an Antisense Therapy for Huntington's Disease

Neuron
Neuroscience
2012English

5-Hiaa Induces Neprilysin to Ameliorate Pathophysiology and Symptoms in a Mouse Model for Alzheimer’s Disease

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2018English

Regional Vulnerability in Huntington's Disease: fMRI-guided Molecular Analysis in Patients and a Mouse Model of Disease

Neurobiology of Disease
Neurology
2013English

Ubiquilin-1 Overexpression Increases the Lifespan and Delays Accumulation of Huntingtin Aggregates in the R6/2 Mouse Model of Huntington's Disease

PLoS ONE
Multidisciplinary
2014English

Corticosterone Dysregulation Exacerbates Disease Progression in the R6/2 Transgenic Mouse Model of Huntington's Disease

Experimental Neurology
Developmental NeuroscienceNeurology
2016English

Factors Modulating the Interaction of Huntingtin With Lipid Membranes: Implications for Huntington's Disease

Biophysical Journal
Biophysics
2016English

Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis

Neuron
Neuroscience
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy